Randomized in situ clinical trial evaluating erosion protection efficacy of a 0.454% stannous fluoride dentifrice
- PMID: 30556372
- PMCID: PMC6850309
- DOI: 10.1111/idh.12379
Randomized in situ clinical trial evaluating erosion protection efficacy of a 0.454% stannous fluoride dentifrice
Abstract
Objectives: To assess the protective effects of a 0.454% stabilized stannous fluoride dentifrice and a marketed triclosan dentifrice against enamel erosion in a 10-day in situ model.
Methods: This was a double-blind, randomized, 2-treatment, 4-period, crossover in situ trial involving healthy adult participants. Participants were randomized to a treatment sequence involving the following products: a highly bioavailable 0.454% stannous fluoride dentifrice (Procter & Gamble) and a marketed dentifrice control containing 0.24% sodium fluoride and 0.3% triclosan (Colgate-Palmolive). Each study period took place over 10 days. Participants wore an intra-oral appliance retaining two polished human enamel samples for 6 hours per day. Two times per day they swished with the assigned dentifrice slurry and four times per day they swished with 250 mL of orange juice (25 mL per minute) over a 10-minute period. Contact profilometry measurements were made for each sample at baseline and day 10 to determine surface change.
Results: Thirty-six participants were enrolled and 33 completed the study (mean age = 40.5 years). The stannous fluoride dentifrice demonstrated 93.5% less enamel loss than the NaF/triclosan dentifrice (P < 0.001) at Day 10, with median enamel loss of 0.097 µm and 1.495 µm, respectively. Both products were well tolerated.
Conclusion: The stannous fluoride dentifrice demonstrated significantly greater erosion protection efficacy relative to the NaF/triclosan dentifrice in this randomized in situ clinical trial.
Keywords: clinical trial; dental erosion; dentifrice; oral hygiene; stannous fluoride.
© 2018 The Authors. International Journal of Dental Hygiene Published by John Wiley & Sons Ltd.
Conflict of interest statement
Professor West, Ms Hellin, Dr Claydon, Dr Seong and Dr Macdonald are all full‐time employees of the University of Bristol Dental School and Hospital, Bristol, UK. Dr He, Dr Farrell, Ms Eusebio and Ms Wilberg are all full‐time employees of The Procter & Gamble Company, Mason, OH, USA.
Figures
References
-
- Lussi A, Carvalho TS. Erosive tooth wear – a multifactorial condition of growing concern and increasing knowledge In: Lussi A, Ganss C. eds. Erosive Tooth Wear: From Diagnosis to Therapy. Monographs in Oral Science. Basel: Karger; 2014:261‐15. - PubMed
-
- Bartlett DW, Lussi A, West NX, Bouchard P, Sanz M, Bourgeois D. Prevalence of tooth wear on buccal and lingual surfaces and possible risk factors in young European adults. J Dent. 2013;41(11):1007‐1013. - PubMed
-
- Salas MM, Nascimento GG, Huysmans MC, Demarco FF. Estimated prevalence of erosive tooth wear in permanent teeth of children and adolescents: an epidemiological systematic review and meta‐regression analysis. J Dent. 2015;43(1):42‐50. - PubMed
-
- Van't Spijker A, Rodriguez JM, Kreulen CM, Bronkhorst EM, Bartlett DW, Creugers NH. Prevalence of tooth wear in adults. Int J Prosthodont. 2009;22(1):35‐42. - PubMed
-
- Smith B, Robb ND. The prevalence of toothwear in 1007 dental patients. J Oral Rehabil. 1996;23:232‐239. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources

